Supplementary Data from CK2 Modulation of NF-κB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides &lt;i&gt;In vitro&lt;/i&gt; or &lt;i&gt;In vivo&lt;/i&gt; via Sub–50-nm Nanocapsules